Facebook Instagram Twitter Youtube
Sunday, December 10, 2023
Facebook Instagram Twitter Youtube
Home AstraZeneca Vaccine, benefits and risks in younger people AstraZeneca Vaccine, benefits and risks in younger people

AstraZeneca Vaccine, benefits and risks in younger people

AstraZeneca, Vaccine, benefits, risks, younger, thrombosis, thrombocytopenia, Oxford, Covid-19, Eurosurveillance, Vaxzevria, European Medical Agency, EMA

The risk of dying from thrombosis and thrombocytopenia in the under 55 age group using the Oxford – AstraZeneca vaccine is HIGHER than the risk of dying from Covid-19 according to a European Government approved analysis.

Chris Woollams Health Watch is an evidence-based, information-only website. We produce short synopses of the latest research in easy-to-understand language. We do NOT answer questions about individual illnesses. However, you can leave comments about the website. Importantly, people with cancer should go to www.canceractive.com People with cancer may apply to be 'buddied' by Chris Woollams in a Personal Prescription
Contact us: [email protected]
Facebook Instagram Twitter Youtube

Trending News

© Copyright 2021 Chris Woollams Health Watch.